This brand name is authorized in Nigeria.
The drug BAFNACARE contains one active pharmaceutical ingredient (API):
1
|
UNII
X4HES1O11F - ACYCLOVIR
|
|
Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-101201 | Tablet | Bafnacare 200 mg Tablets TAB 200 mg 5 x 5's ( in Alu-PVC blisters) | Uncoated Tablet White to off white, capsule shaped, biconvex, uncoated tablets debossed “ACV” on one side and “200” on other side BAFNACARE 200MG TABLET ACICLOVIR BP 200MG ACICLOVIR 200MG, CORN STARCH, MAGNESIUM STEARATE Drugs Imported Product 55 06-09-2024 ANNYGOD PHARMACEUTICAL COMPANY LTD, 28 UKWULU STREET, AWADA OBOSI, ANAMBRA STATE 046820296 annygod_pharma@hotmail.com BAFNA PHARMACEUTICAL LTD., NO. 147, MADHAVARAM REDHILLS HIGH ROAD, GRANTLYON VILLAGE, VADAKARI POST, CHENNAI-600 052. INDIA. | 28/02/2025 |
| A4-101202 | Tablet | Bafnacare 400 Tablet TAB 400 mg 4 x 14's (in Alu-PVC blisters) | Uncoated Tablet White to off white, capsule shaped, biconvex, uncoated tablets debossed “ACV” on one side and “400” on other side BAFNACARE 400 TABLET ACICLOVIR BP 400MG ACICLOVIR BP 400MG, MAIZE STARCH, COLLOIDAL ANHYDROUS SILICA, MAGNESIUM STEARARTE, PURIFIED TALC, ISOPROPYL ALCOHOL Drugs Imported Product 414 22-06-2022 ANNYGOD PHARMACEUTICAL COMPANY LTD, 28 UKWULU STREET, AWADA OBOSI, ANAMBRA STATE 046820296 annygod_pharma@hotmail.com BAFNA PHARMACEUTICAL LTD., NO. 147, MADHAVARAM REDHILLS HIGH ROAD, GRANTLYON VILLAGE, VADAKARI POST, CHENNAI-600 052. INDIA. | 28/02/2025 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J05AB01 | Aciclovir | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-101201, A4-101202 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.